Latest News
“Many, however, have already advised people to consider starting screening mammograms at age 40,” said Maryam Lustberg, director of the Center for Breast Cancer at Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut.
- May 08, 2024
James Hansen, MD, MS, participates in a Q&A in honor of Brain Tumor Awareness Month.
- May 08, 2024
Smilow Shares with Primary Care: Breast Cancer
- May 08, 2024
Amos S. Espinosa, a PhD Candidate in Experimental Pathology, was recently named a winner of the American Society of Hematology's Minority Hematology Graduate Award.
- May 08, 2024Source: Yale News
In the body, certain enzymes are key to cell communication and their dysfunction can lead to cancer. A new study begins to uncover how they signal and when.
- May 07, 2024Source: SurvivorNet
“Cancer care is multidisciplinary, and a team approach is simply the best way to organize it,” Dr. Elizabeth Berger tells SurvivorNet. Berger is a breast surgical oncologist in The Breast Center at Yale Cancer Center in New Haven, CT.
- May 07, 2024Source: VeryWell Health
This work “appears promising,” said Harry Aslanian, MD, gastroenterologist and pancreatic cancer expert at Yale Cancer Center, who wasn’t involved with the study. Combining the markers found in exosomes and in the blood allows the test to get a fuller “fingerprint” of the cancer, he said.
- May 07, 2024
Yale Cancer Center and Smilow Cancer Hospital uphold the most rigorous standards in every aspect of transplantation and cellular therapy – from clinical care to donor management, cell collection, processing, storage, transportation, administration, and cell release. There are currently 310 FACT-accredited institutions worldwide.
- May 07, 2024Source: WWLP 22News (NBC)
These are the types of studies that will help to get to the bottom of this issue. Yale Cancer Center director and president and physician-in-chief of Smilow Cancer Hospital, Dr. Eric Winer, says many people think these cancer mortality rates among African-Americans are related to genetics. "I personally think that it's probably much more related to social reasons, socioeconomic factors, and racism in our country." He says it also comes down to the access that this racial group has to receiving the care that they need.
- May 07, 2024Source: Urology Times
In this interview, David Braun, MD, PhD, and Patrick Kenney, MD, describe their practices and touch on unmet needs in kidney cancer treatment.